User profiles for Braulio A. Marfil-Garza

Braulio A Marfil-Garza

Director of Pancreatic Islet Transplantation - Tec de Monterrey
Verified email at tec.mx
Cited by 577

Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada

BA Marfil-Garza, S Imes, K Verhoeff, J Hefler… - The lancet Diabetes & …, 2022 - thelancet.com
Background Islet transplantation offers an effective treatment for selected people with type 1
diabetes and intractable hypoglycaemia. Long-term experience, however, remains limited. …

[HTML][HTML] Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico

BA Marfil-Garza, PF Belaunzarán-Zamudio… - PloS one, 2018 - journals.plos.org
Background Hospital length-of-Stay has been traditionally used as a surrogate to evaluate
healthcare efficiency, as well as hospital resource utilization. Prolonged Length-of-stay (PLOS…

[HTML][HTML] A predictive computational platform for optimizing the design of bioartificial pancreas devices

…, LH Wang, SC Worland, BA Marfil-Garza… - Nature …, 2022 - nature.com
The delivery of encapsulated islets or stem cell-derived insulin-producing cells (ie, bioartificial
pancreas devices) may achieve a functional cure for type 1 diabetes, but their efficacy is …

Clinical islet transplantation: current progress and new frontiers

BA MarfilGarza, AMJ Shapiro… - Journal of Hepato‐Biliary …, 2021 - Wiley Online Library
Braulio A. Marfil-Garza is currently supported by the Patronato del Instituto Nacional de
Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), the Fundación para la Salud y la …

Progress in translational regulatory T cell therapies for type 1 diabetes and islet transplantation

BA Marfil-Garza, J Hefler… - Endocrine …, 2021 - academic.oup.com
Regulatory T cells (Tregs) have become highly relevant in the pathophysiology and treatment
of autoimmune diseases, such as type 1 diabetes (T1D). As these cells are known to be …

[HTML][HTML] Inducible pluripotent stem cells as a potential cure for diabetes

K Verhoeff, SJ Henschke, BA Marfil-Garza… - Cells, 2021 - mdpi.com
Over the last century, diabetes has been treated with subcutaneous insulin, a discovery that
enabled patients to forego death from hyperglycemia. Despite novel insulin formulations, …

[HTML][HTML] Mitochondrial regulation in human pluripotent stem cells during reprogramming and β cell differentiation

…, K Verhoeff, BA Marfil-Garza… - Frontiers in …, 2023 - frontiersin.org
Mitochondria are the powerhouse of the cell and dynamically control fundamental biological
processes including cell reprogramming, pluripotency, and lineage specification. Although …

The low‐harm score for predicting mortality in patients diagnosed with COVID‐19: a multicentric validation study

A Soto‐Mota, BA MarfilGarza… - Journal of the …, 2020 - Wiley Online Library
Objective We sought to determine the accuracy of the LOW‐HARM score (Lymphopenia,
Oxygen saturation, White blood cells, Hypertension, Age, Renal injury, and Myocardial injury) …

Outcomes following extrahepatic and intraportal pancreatic islet transplantation: a comparative cohort study

K Verhoeff, BA Marfil-Garza, G Sandha, D Cooper… - …, 2022 - journals.lww.com
Marfil-Garza contributed equally to this work. … Verhoeff K, Henschke SJ, Marfil-Garza BA, et
al. Inducible pluripotent stem … Verhoeff K, Marfil-Garza BA, Shapiro AMJ. Update on islet cell …

Long-term outcomes after normothermic machine perfusion in liver transplantation—Experience at a single North American center

J Hefler, D Leon-Izquierdo, BA Marfil-Garza… - American Journal of …, 2023 - Elsevier
Normothermic machine perfusion (NMP) has emerged as a valuable tool in the preservation
of liver allografts before transplantation. Randomized trials have shown that replacing static …